Innoviz Technologies Ltd (INVZ) concluded trading on Wednesday at a closing price of $1.55, with 3.95 million shares of worth about $6.12 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 91.81% during that period and on January 29, 2025 the price saw a loss of about -6.06%. Currently the company’s common shares owned by public are about 168.68M shares, out of which, 168.68M shares are available for trading.
Stock saw a price change of -17.99% in past 5 days and over the past one month there was a price change of -13.41%. Year-to-date (YTD), INVZ shares are showing a performance of -7.74% which decreased to -8.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.45 but also hit the highest price of $3.14 during that period. The average intraday trading volume for Innoviz Technologies Ltd shares is 7.93 million. The stock is currently trading -11.88% below its 20-day simple moving average (SMA20), while that difference is up 26.08% for SMA50 and it goes to 62.18% higher than SMA200.
Innoviz Technologies Ltd (NASDAQ: INVZ) currently have 168.68M outstanding shares and institutions hold larger chunk of about 32.42% of that.
The stock has a current market capitalization of $261.46M and its 3Y-monthly beta is at 0.72. It has posted earnings per share of -$0.64 in the same period. It has Quick Ratio of 3.59 while making debt-to-equity ratio of 0.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INVZ, volatility over the week remained 10.78% while standing at 15.97% over the month.
Stock’s fiscal year EPS is expected to rise by 33.85% while it is estimated to increase by 7.44% in next year. EPS is likely to shrink at an annualized rate of 22.62% for next 5-years, compared to annual growth of 24.35% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Rosenblatt on December 20, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. On July 11, 2024, Goldman Downgrade their recommendations, while on October 25, 2022, Rosenblatt Initiated their ratings for the stock with a price target of $5. Stock get a Buy rating from Berenberg on September 28, 2022.
